Search results

• Ethics

  Responsible and ethical behaviour is fundamental to the way we operate at Croda.

• Procurement and sustainable sourcing

  Using natural resources brings a responsibility to ensure no associated negative social or environmental impacts, and an opportunity to advocate and contribute to positive change.

• Sustainability

  Sustainability spans every area of our business and is a crucial way we add value to our customers.

• Investor seminar on our sustainability strategy

  20 October 2020: Steve Foots, CEO and other senior members of our management team provided a comprehensive overview of our 2030 sustainability Commitment.

• Global Graduate Development Programme Opportunities

  Our programme for recent graduates offers a unique experience. All schemes enable you to quickly grow an understanding of the business and the different areas within.

• Rewarding careers at Croda

  Find out more about the rewards available at Croda.

• Current vacancies

  At Croda, our people are our difference. We are committed to using Smart science to improve lives™ while driving a sustainable future. Join our team and be part of a responsible, inclusive culture where your contributions make an impact.

• Bank of America Beauty Event

  16 May 2025: Croda International plc hosted a Croda Beauty Event with Bank of America.

• Site visit to Incotec Seed Treatment business in the Netherlands

  11 April 2018: Croda International plc hosted an investor event for analysts and investors on 11 April 2018 at its Incotec facility in the Netherlands and concluded on 12 April 2018 with a series of presentations in Amsterdam.

• Jefferies visit to Grasse May 2025

  22 May 2025: Croda International plc hosted Jefferies at a tour of our F&F site, Parfex in Grasse, France.

• Biotechnology in Personal Care

  Explore the role of biotechnology in the personal care industry and its potential to become the innovative new toolset of choice in our detailed report.

• Croda urges G20 leaders to keep Paris Agreement within reach

  Croda is signatory to an open letter to all G20 leaders, urging them to keep the Paris Agreement’s 1.5°C goal within reach.

• Signatory to the if not now then when campaign

  We have joined over 70 major UK businesses in becoming a signatory to the Black inclusion business campaign.

• Celebrating our innovative ingredients: Zenakine™ - redefining neurocosmetic skincare possibilities

  8 September 2025: Croda International Plc (“Croda”), the company that uses smart science to create high-performance ingredients and solutions that improve lives, has recently launched Zenakine™, a biotech-based neuroactive ingredient designed to counteract the effects of stress on the skin.

• Biotechnology in Home Care

  This report will outline and discuss the opportunities to meet sustainability and innovation goals within home care.

• Partner with us

  Innovation thrives when it’s driven by a diverse mix of ideas, this is why we always look to collaborate and share insight with our industry partners.

• Biotechnology at Croda

  Our innovation is focused on sustainability and, in particular, biotechnology, enhancing the sustainability of our processes and products.

• Specialist biotechnology capabilities

  At Croda, thanks to our expertise across a wide range of biotechnology specialisms, we are developing new, innovative and sustainable ingredients to support our customers in bringing to market exciting often niche products.

• Our strategy

  Our focus on innovation, sustainability and growth ensures that Croda smart science helps our customers meet their own sustainability targets as well as consumer demands.

• Megatrends

  Trends which will influence market demand and growth at Croda, Providing new opportunities and shaping our approach.

• Our Values

  At Croda, our company core values of Responsible, Innovative, and Together are at the heart of how we operate, shaping a unique, collaborative culture that supports our Purpose.

• Our Fundamentals

  We will consider all stakeholders in our ecosystem and adopt best practices in environment, labour and human rights, ethics and sustainable procurement.

• Nature Positive

  By 2030, we will be Nature Positive.

• Safety

  Behavioural and process safety are extremely important for us at Croda, the safety of our employees and neighbours is of paramount importance.

• Behind the Science

  Discover how Croda’s high-quality ingredients, scientific expertise and sustainable innovation deliver end-to-end solutions that power growth across Consumer Care and Life Sciences.

• Meet the expert: Dhanila Varkey, Applications Team Lead

  Discover how Croda’s applications expert Dhanila Varkey is using nanotechnology to improve targeting, absorption and effectiveness in topical and transdermal drug delivery.

• Governance

  Our Board are responsible for good governance and are committed to the highest standards of corporate governance.

• Meet the expert: Will Small, Research & Technology Specialist

  Will shares how high-purity and super refined excipients help improve consistency and stability, and how they’re being leveraged in new active formulations to drive innovation and growth.

• Meet the expert: Chris Wells, Applications Team Lead

  Meet the expert: Chris Wells, Applications Team Lead

• Our targets

  We are developing our sustainability strategy to 2030, ensuring our alignment to the United Nations Sustainable Development Goals (SDGs).

• Your ingredients partner powering health innovation

  Explore how Croda’s smart science, people and high-performance ingredients are shaping the future of Life Sciences and enabling safer, more sustainable innovation.

• Leadership

  Our Board and Executive Committee provide leadership in delivering for our customers and achieving our strategic priorities.

• Croda Foundation

  Introduction to the Croda Foundation, the independently managed, philanthropic arm of Croda International.

• Sustainability Impact Report 2024

  Find our 2024 Sustainability Impact Report here

• Steve Foots, CEO Sustainability Statement 2024

  One of our core philosophies is to take a leadership position in sustainability and innovation in our chosen markets.

• Materiality assessment

  Our Materiality Assessment performed a comprehensive value chain assessment, and identified areas of transformative action within the business

• Sustainability Report archive

  View our sustainability report archives.

• Croda acquires innovative seed enhancement company Incotec

  Operating in one of the fastest growing segments within the crop care market, Incotec develop and supply a wide range of proprietary and sustainable technologies for both vegetable seeds and field crops.

• Acquisition of Iberchem expands reach into high growth fragrances market

  Acquiring the entire issued share capital of Fragrance Spanish Topco, S.L., trading as Iberchem (“the acquisition”), a leading global fragrances and flavours (“F&F”) company.

• Strengthening Life Sciences with the acquisition of Avanti Polar Lipids

  A leader in drug delivery systems for next generation pharmaceuticals, the acquisition more than doubles Croda’s research and development (R&D) capability in drug delivery.

• Strategic investment Entekno Materials

  A new Smart Partnership focused on the development of a new particle technology that will deliver superior protection benefits to the sun care and personal care markets.

• Acquisition of global vaccine adjuvant specialist

  Vaccine adjuvants are a natural extension to Croda’s market leading, high-purity excipient delivery systems in its Health Care business., these adjuvants represent a niche, high-growth market.

• Vietnam

  Croda’s Vietnam office was founded in 2012 and is located in Ho Chi Minh City.

• Brazil

  Croda do Brasil was established in 1974 and the Campinas manufacturing site in 1977.

• Mexico

  In 1977, a joint venture company was formed in Mexico, Quimica Croda SA.

• Croda Half Year Results fireside chat with Morgan Stanley

  Watch our fireside chat with Morgan Stanley from 29 July 2025.

• PTIC divestment

  View the full webinar from the 22 December 2021 discussing the agreement to divest the majority of our PTIC businesses to Cargill Inc.

• Third quarter trading update

  Update on trading from 01 July to 30 September 2023

• Half year 2024 results

  Group performance in line with expectations reflecting more stable market conditions and operational progress

• UK Government to support expansion of Croda's lipid systems manufacturing facility

  31 March 2022: This investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines.